Piclidenoson Completed Phase 2 Trials for Rheumatoid Arthritis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00280917Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
NCT01034306Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis